Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Samrat Pharmachem Ltd
Samrat Pharmachem Ltd

Samrat Pharmachem Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 427
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹253.30
₹1.00 (0.40%)
250.00Low
Today’s Performance
258.95High
245.00Low
52 Week’s Performance
449.45High

bt_logoStock Performance

  • 1 Day0.40%
  • 1 Week-0.82%
  • 1 Month-9.58%
  • 3 Months-20.91%
  • 6 Months-28.08%
  • 1 Year-38.21%
  • 3 Years-30.38%
  • 5 Years12.67%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.93
  • 52-Week Low (₹)245.00
  • 52-Week High (₹)449.45
  • Price-to-Book (X)*1.11
  • Dividend Yield (%)0.39
  • Price-to-Earnings (P/E) (X)*49.86
  • Earnings Per Share (₹)5.08
  • Market Cap (₹ Cr.)*78.26
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Will Pharma & Hospitals Lead Markets in 2026? | Portfolio Strategy Revealed2:37Will Pharma & Hospitals Lead Markets In 2026? | Portfolio Strategy Revealed
Can India Sustain 8%+ Growth? Inflation and other Challenges Explained2:30Can India Sustain 8%+ Growth? Inflation And Other Challenges Explained
"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
View more

bt_logoFAQ's

What was Samrat Pharmachem Ltd share price previously?
Samrat Pharmachem Ltd share price was up by 0.40% from the previous closing price of ₹252.30.
Who are peers of Samrat Pharmachem Ltd?
The peers of Samrat Pharmachem Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Samrat Pharmachem Ltd?
The promotor/promotors of Samrat Pharmachem Ltd are Lalit Mehta, Rajesh Mehta, Megh Mehta, Manishkumar Pipalia, Sachin Kothary, Megha Jain, Piyush Dharod, Nishant Kankaria.
What has been 52-week high of Samrat Pharmachem Ltd stocks?
The highest price of Samrat Pharmachem Ltd stock is ₹449.45 in the last 52-week.
What is the share price of Samrat Pharmachem Ltd (SAMRATPH) today on BSE?
As on Dec 05, 2025 Samrat Pharmachem Ltd (SAMRATPH)’s share price on BSE is Rs 253.3
What is the market cap of Samrat Pharmachem Ltd (SAMRATPH)?
The current market capitalisation of Samrat Pharmachem Ltd (SAMRATPH) is 78.26 crores
What is Samrat Pharmachem Ltd Share symbol?
The symbol of Samrat Pharmachem Ltd is .
What is the PE ratio of Samrat Pharmachem Ltd (SAMRATPH)?
The current PE ratio of Samrat Pharmachem Ltd (SAMRATPH) is 49.86.
What is the PB ratio of Samrat Pharmachem Ltd (SAMRATPH)?
The current PB ratio of Samrat Pharmachem Ltd (SAMRATPH) is 1.11.
Today’s High & Low share prices of Samrat Pharmachem Ltd (SAMRATPH) on BSE?
Today, the share price of Samrat Pharmachem Ltd (SAMRATPH) on BSE touched a high of Rs 258.95 and a low of Rs 250
What price did Samrat Pharmachem Ltd (SAMRATPH) shares open on the BSE today?
On BSE, the share price of Samrat Pharmachem Ltd (SAMRATPH) opened at Rs 253
What is the 52-week high of Samrat Pharmachem Ltd (SAMRATPH)?
The 52-week high price of Samrat Pharmachem Ltd (SAMRATPH) is Rs 449.45
What is the 52-week low of Samrat Pharmachem Ltd (SAMRATPH)?
The 52-week low price of Samrat Pharmachem Ltd (SAMRATPH) is Rs 245.00

bt_logoAbout Samrat Pharma

Samrat Pharmachem Ltd, incorporated in the year 1992, has its registered office in Plot No A2/3445, GIDC Phase IV, Ankleshwar, Gujarat, 393002, 91-2646-220774, 91-2646-251291. The main industry in which Samrat Pharmachem Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Samrat Pharmachem Ltd is/are Shah & Savla LLP. In the main management, Lalit Mehta is chairman and Nishant Kankaria is the company secretary for Samrat Pharmachem Ltd.

  • LM
    Lalit MehtaChairman & Managing Director
  • RM
    Rajesh MehtaED / WTD / CFO / Promoter
  • MM
    Megh MehtaWhole Time Executive Director
  • MP
    Manishkumar PipaliaIndependent Non Exe. Director
  • SK
    Sachin KotharyIndependent Non Exe. Director
  • MJ
    Megha JainIndependent Non Exe. Director
  • PD
    Piyush DharodIndependent Non Exe. Director
  • NK
    Nishant KankariaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.